Isotretinoin: Time to reconsider blood test best practices
Randy Dotinga
Abstract
Randy Dotinga
Abstract
While oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
While oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.
Key concepts: Medicine, Isotretinoin, Blood test, Dermatology, Test (biology), Clinical pharmacology, Intensive care medicine, Family medicine